Search - Prime Therapeutics

472 Results for GLP-1 Pipeline Update

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

Maryam Tabatabai, PharmD, associate vice president of clinical information, offers predictions about forthcoming drug approvals, the latest on a new voucher pilot, updated biosimilar guidance and more

PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Perspectives
April Fraud Focus: How to identify counterfeit GLP-1 weight-loss drugs

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common GLP-1 fraud schemes

PA Sub-Categories: GLP-1 Prime Article: Perspectives
GLP-1 Resources

GLP-1 year two cost effectiveness study abstract
Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Real-world study of GLP-1 patients continues to deliver leading insights

PA Sub-Categories: GLP-1 Prime Article: Press Releases